Higher levels of well-being may help reduce the risk of memory loss in middle age, suggests new research, which tracked more ...

Two drugs to treat Alzheimer’s disease have been rejected for use on the NHS because their benefits are “too small” to ...

Donanemab and lecanemab are targeted antibody drugs that slow down the early stages of Alzheimer’s. They represent a huge ...

A care agency where staff worked 12-hour back-to-back shifts and patients were filmed in bedrooms without permission has been ...